{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:00:07Z","timestamp":1762866007054},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T00:00:00Z","timestamp":1338940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/ja.2012.43","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T09:29:59Z","timestamp":1338974999000},"page":"397-404","source":"Crossref","is-referenced-by-count":32,"title":["Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion"],"prefix":"10.1038","volume":"65","author":[{"given":"Tofeeq","family":"Ur-Rehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Slepenkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hencelyn","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Blomgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus K","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline E","family":"Zetterstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellena M","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Elofsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Gylfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,6]]},"reference":[{"key":"BFja201243_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2796.2008.01941.x","volume":"264","author":"P Keyser","year":"2008","unstructured":"Keyser, P., Elofsson, M., Rosell, S. & Wolf-Watz, H. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J. Intern. Med. 264, 17\u201329 (2008).","journal-title":"J. Intern. Med."},{"key":"BFja201243_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mib.2009.12.003","volume":"13","author":"C Baron","year":"2010","unstructured":"Baron, C. Antivirulence drugs to target bacterial secretion systems. Curr. Opin. Microbiol. 13, 100\u2013105 (2010).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFja201243_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1074-5521(03)00046-2","volume":"10","author":"AM Kauppi","year":"2003","unstructured":"Kauppi, A. M., Nordfelth, R., Uvell, H., Wolf-Watz, H. & Elofsson, M. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10, 241\u2013249 (2003).","journal-title":"Chem. Biol."},{"key":"BFja201243_CR4","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1128\/IAI.73.5.3104-3114.2005","volume":"73","author":"R Nordfelth","year":"2005","unstructured":"Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H. & Elofsson, M. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73, 3104\u20133114 (2005).","journal-title":"Infect. Immun."},{"key":"BFja201243_CR5","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1128\/AAC.00223-07","volume":"51","author":"A Negrea","year":"2007","unstructured":"Negrea, A. et al. Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 51, 2867\u20132876 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201243_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1128\/JB.01004-08","volume":"191","author":"AK Veenendaal","year":"2009","unstructured":"Veenendaal, A. K., Sundin, C. & Blocker, A. J. Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton. J. Bacteriol. 191, 563\u2013570 (2009).","journal-title":"J. Bacteriol."},{"key":"BFja201243_CR7","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1128\/IAI.00562-09","volume":"77","author":"JJ Tree","year":"2009","unstructured":"Tree, J. J. et al. Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7. Infect. Immun. 77, 4209\u20134220 (2009).","journal-title":"Infect. Immun."},{"key":"BFja201243_CR8","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1128\/AAC.01492-06","volume":"51","author":"DL Hudson","year":"2007","unstructured":"Hudson, D. L. et al. Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors. Antimicrob Agents Chemother 51, 2631\u20132635 (2007).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja201243_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/j.1365-2958.2006.05347.x","volume":"61","author":"K Wolf","year":"2006","unstructured":"Wolf, K. et al. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61, 1543\u20131555 (2006).","journal-title":"Mol. Microbiol."},{"key":"BFja201243_CR10","doi-asserted-by":"publisher","first-page":"14566","DOI":"10.1073\/pnas.0606412103","volume":"103","author":"S Muschiol","year":"2006","unstructured":"Muschiol, S. et al. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl Acad. Sci. USA 103, 14566\u201314571 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja201243_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.febslet.2007.01.013","volume":"581","author":"L Bailey","year":"2007","unstructured":"Bailey, L. et al. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett. 581, 587\u2013595 (2007).","journal-title":"FEBS Lett."},{"key":"BFja201243_CR12","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1128\/IAI.00023-07","volume":"75","author":"A Slepenkin","year":"2007","unstructured":"Slepenkin, A. et al. Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun 75, 3478\u20133489 (2007).","journal-title":"Infect Immun"},{"key":"BFja201243_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1128\/9781555818203.ch6","volume-title":"Chlamydia: Intracellular Biology, Pathogenesis and Immunity.","author":"J Schachter","year":"1999","unstructured":"Schachter, J. in Chlamydia: Intracellular Biology, Pathogenesis and Immunity. ed. Stephens R. S. Ch. 6, 139\u2013169 Am Soc Microbiol, (1999)."},{"key":"BFja201243_CR14","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/OLQ.0b013e3181812d15","volume":"35","author":"LF Johnson","year":"2008","unstructured":"Johnson, L. F. & Lewis, D. A. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm. Dis. 35, 946\u2013959 (2008).","journal-title":"Sex Transm. Dis."},{"key":"BFja201243_CR15","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1016\/j.bmc.2010.02.022","volume":"18","author":"MK Dahlgren","year":"2010","unstructured":"Dahlgren, M. K., Zetterstr\u00f6m, C. E., Gylfe, \u00c5., Linusson, A. & Elofsson, M. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium. Yersinia. Bioorg. Med. Chem. 18, 2686\u20132703 (2010).","journal-title":"Yersinia. Bioorg. Med. Chem."},{"key":"BFja201243_CR16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/IAI.31.3.1161-1176.1981","volume":"31","author":"HD Caldwell","year":"1981","unstructured":"Caldwell, H. D., Kromhout, J. & Schachter, J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31, 1161\u20131176 (1981).","journal-title":"Infect. Immun."},{"key":"BFja201243_CR17","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1128\/JCM.40.6.2273-2274.2002","volume":"40","author":"Y Kuoppa","year":"2002","unstructured":"Kuoppa, Y. et al. Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR. J. Clin. Microbiol. 40, 2273\u20132274 (2002).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201243_CR18","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","volume":"267","author":"J O'Brien","year":"2000","unstructured":"O'Brien, J., Wilson, I., Orton, T. & Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267, 5421\u20135426 (2000).","journal-title":"Eur. J. Biochem."},{"key":"BFja201243_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Huo, M. R., Zhou, J. P. & Xie, S. F. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine 99, 306\u2013314 (2010).","journal-title":"Computer Methods and Programs in Biomedicine"},{"key":"BFja201243_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijantimicag.2010.03.018","volume":"36","author":"H Chu","year":"2010","unstructured":"Chu, H. et al. Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae. Int. J. Antimicrob. Agents 36, 145\u2013150 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja201243_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","volume":"59","author":"DH Owen","year":"1999","unstructured":"Owen, D. H. & Katz, D. F. A vaginal fluid simulant. Contraception 59, 91\u201395 (1999).","journal-title":"Contraception"},{"key":"BFja201243_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1128\/AAC.01343-09","volume":"54","author":"PM Roblin","year":"2010","unstructured":"Roblin, P. M., Kohlhoff, S. A., Parker, C. & Hammerschlag, M. R. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. Antimicrob. Agents Chemother. 54, 1358\u20131359 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201243_CR23","unstructured":"Wang, D. et al. Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence blocking compounds. J. Biol. Chem. (2011)."},{"key":"BFja201243_CR24","first-page":"957","volume":"29","author":"RE White","year":"2001","unstructured":"White, R. E. & Manitpisitkul, P. Pharmacokinetic theory of cassette dosing in drug discovery screening. Drug Metab. Dispos. 29, 957\u2013966 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"BFja201243_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijantimicag.2010.01.023","volume":"35","author":"A Barbour","year":"2010","unstructured":"Barbour, A., Scaglione, F. & Derendorf, H. Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic\/pharmacodynamic indices. Int. J. Antimicrob. Agents 35, 431\u2013438 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja201243_CR26","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/infdis\/jir552","volume":"204","author":"A Slepenkin","year":"2011","unstructured":"Slepenkin, A., Chu, H., Elofsson, M., Keyser, P. & Peterson, E. M. Protection of mice from a Chlamydia trachomatis vaginal infection using a salicylidene acylhydrazide, a potential microbicide. J. Infect. Dis. 204, 1313\u20131320 (2011).","journal-title":"J. Infect. Dis."},{"key":"BFja201243_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1124\/pr.107.07110","volume":"60","author":"AW Maresso","year":"2008","unstructured":"Maresso, A. W. & Schneewind, O. Sortase as a target of anti-infective therapy. Pharmacol. Rev. 60, 128\u2013141 (2008).","journal-title":"Pharmacol. Rev."},{"key":"BFja201243_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.1160354","volume":"321","author":"DA Rasko","year":"2008","unstructured":"Rasko, D. A. et al. Targeting QseC signaling and virulence for antibiotic development. Science 321, 1078\u20131080 (2008).","journal-title":"Science"},{"key":"BFja201243_CR29","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1016\/j.bmcl.2007.07.072","volume":"17","author":"TE Bowser","year":"2007","unstructured":"Bowser, T. E. et al. Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors. Bioorg. Med. Chem. Lett. 17, 5652\u20135655 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFja201243_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijantimicag.2011.03.015","volume":"38","author":"AR Bhengraj","year":"2011","unstructured":"Bhengraj, A. R., Srivastava, P. & Mittal, A. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin. Int. J. Antimicrob. Agents 38, 178\u2013179 (2011).","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja201243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201243","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:18:32Z","timestamp":1684430312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,6]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFja201243"],"URL":"https:\/\/doi.org\/10.1038\/ja.2012.43","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,6]]}}}